Personalized cancer vaccine promises remission

Clonality, trafficking, and molecular alterations among Hprt mutant T lymphocytes isolated from control mice versus mice treated with N-ethyl-N-nitrosourea.

Environmental and molecular mutagenesis·2023

Nanodevices hold promise for gene therapy.

Drug discovery today·2003

Pharmacological targeting of GCN5/PCAF (KAT2A/B): Current drug discovery strategies and translational potential.

Drug discovery today·2026

Artificial intelligence agents and agentic artificial intelligence applied to precision medicine.

Drug discovery today·2026

China's drug discovery strategy: established targets, combination approaches, and small-molecule optimization.

Drug discovery today·2026

mRNA therapeutics for restoring immune tolerance in autoimmune diseases.

Drug discovery today·2026

Sustainable drug delivery systems: Biodegradable carriers for a carbon-neutral pharma future.

Drug discovery today·2026

Designing time-limited aryl hydrocarbon receptor drugs: A kinetic framework from the FICZ-CYP1A1 feedback axis.

Drug discovery today·2026

Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study.

Frontiers in oncology·2026

Chitosan Nanoparticles for the Treatment of Ischemia-Reperfusion Injury: Mechanisms, Preclinical Evidence, Challenges, and Future Perspectives.

Journal of drug targeting·2026

Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.

Human vaccines & immunotherapeutics·2026

CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.

Hematology (Amsterdam, Netherlands)·2026

Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.

Asia-Pacific journal of clinical oncology·2026

Prognostic factors and outcomes associated with postmastectomy radiation therapy following neoadjuvant chemotherapy and mastectomy for breast cancer: A retrospective cohort study.

Medicine·2026

Related Experiment Videos

Personalized cancer vaccine promises remission

Related Concept Videos

Clonality, trafficking, and molecular alterations among Hprt mutant T lymphocytes isolated from control mice versus mice treated with N-ethyl-N-nitrosourea.

Nanodevices hold promise for gene therapy.

Pharmacological targeting of GCN5/PCAF (KAT2A/B): Current drug discovery strategies and translational potential.

Artificial intelligence agents and agentic artificial intelligence applied to precision medicine.

China's drug discovery strategy: established targets, combination approaches, and small-molecule optimization.

mRNA therapeutics for restoring immune tolerance in autoimmune diseases.

Sustainable drug delivery systems: Biodegradable carriers for a carbon-neutral pharma future.

Designing time-limited aryl hydrocarbon receptor drugs: A kinetic framework from the FICZ-CYP1A1 feedback axis.

Time to adjuvant chemotherapy after cytoreductive surgery and survival outcomes in epithelial ovarian cancer: a retrospective cohort study.

Chitosan Nanoparticles for the Treatment of Ischemia-Reperfusion Injury: Mechanisms, Preclinical Evidence, Challenges, and Future Perspectives.

Cost‑effectiveness of first‑line immunotherapy-based combination regimens for advanced renal cell carcinoma in China and the United States.

CD7 CAR-T cells eliminate chronic myeloid leukemia stem cells specifically and effectively.

Impact of Immunotherapy Prescribing Restrictions on Time to Systemic Therapy and Outcomes in Metastatic Clear Cell Renal Carcinoma in Australia.

Prognostic factors and outcomes associated with postmastectomy radiation therapy following neoadjuvant chemotherapy and mastectomy for breast cancer: A retrospective cohort study.

Related Experiment Videos

Personalized cancer vaccine promises remission

Related Concept Videos

Related Articles